Profile
Charlotte Dyring is the founder.
Founded ExpreS2ion Biotechnologies ApS in 2009 as Chief Operating Officer.
Founded Expres2ion Biotech Holding AB in 2010 as Chief Operating Officer.
Founded Kripthonite Therapeutics ApS in 2023 as Chief Operating Officer.
Former job at Pharmexa A as Principal.
Former job at Kabi Pharmacia as Principal.
Education includes a doctorate from Technical University of Denmark conferred in 1992 and an undergraduate degree from The Danish Academy of Technical Sciences.
Charlotte Dyring active positions
| Companies | Position | Start |
|---|---|---|
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology Operates as a biotech company which engages in the field of protein production in Drosophila Schneider-2 cells | Founder | 2008-12-31 |
Former positions of Charlotte Dyring
| Companies | Position | End |
|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Founder | 2020-11-30 |
Pharmexa A/S
Pharmexa A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Corporate Officer/Principal | - |
Kabi Pharmacia | Corporate Officer/Principal | - |
Training of Charlotte Dyring
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Pharmexa A/S
Pharmexa A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Technical University of Denmark
Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Danish Academy of Technical Sciences
The Danish Academy of Technical Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kabi Pharmacia | |
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology Operates as a biotech company which engages in the field of protein production in Drosophila Schneider-2 cells | Health Technology |
Expres2ion Biotech Holding AB
Expres2ion Biotech Holding AB BiotechnologyHealth Technology Engages in the development of a portfolio of vaccines for diseases such as COVID-19, influenza, and breast cancer | Health Technology |
- Stock Market
- Insiders
- Charlotte Dyring
















